LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | WZ3105 | 3.33 | uM | LJP5 | 72 | hr | 929 | 839 | 3237 | 0.2592 | -0.0552 |
Hs 578T | WZ3105 | 10 | uM | LJP5 | 72 | hr | 929 | 913 | 3237 | 0.2824 | -0.0096 |
Hs 578T | XMD11-50 | 0.04 | uM | LJP6 | 72 | hr | 929 | 3165 | 3216 | 0.9841 | 0.9823 |
Hs 578T | XMD11-50 | 0.12 | uM | LJP6 | 72 | hr | 929 | 3059 | 3216 | 0.9513 | 0.9449 |
Hs 578T | XMD11-50 | 0.37 | uM | LJP6 | 72 | hr | 929 | 2719 | 3216 | 0.8454 | 0.8210 |
Hs 578T | XMD11-50 | 1.11 | uM | LJP6 | 72 | hr | 929 | 2327 | 3216 | 0.7235 | 0.6695 |
Hs 578T | XMD11-50 | 3.33 | uM | LJP6 | 72 | hr | 929 | 1644 | 3216 | 0.5112 | 0.3752 |
Hs 578T | XMD11-50 | 10 | uM | LJP6 | 72 | hr | 929 | 962 | 3216 | 0.2991 | 0.0195 |
Hs 578T | XMD11-85h | 0.04 | uM | LJP6 | 72 | hr | 929 | 3182 | 3216 | 0.9894 | 0.9881 |
Hs 578T | XMD11-85h | 0.12 | uM | LJP6 | 72 | hr | 929 | 3107 | 3216 | 0.9659 | 0.9615 |
Hs 578T | XMD11-85h | 0.37 | uM | LJP6 | 72 | hr | 929 | 3006 | 3216 | 0.9348 | 0.9260 |
Hs 578T | XMD11-85h | 1.11 | uM | LJP6 | 72 | hr | 929 | 2949 | 3216 | 0.9170 | 0.9056 |
Hs 578T | XMD11-85h | 3.33 | uM | LJP6 | 72 | hr | 929 | 2808 | 3216 | 0.8730 | 0.8538 |
Hs 578T | XMD11-85h | 10 | uM | LJP6 | 72 | hr | 929 | 1611 | 3216 | 0.5006 | 0.3584 |
Hs 578T | XMD16-144 | 0.04 | uM | LJP5 | 72 | hr | 929 | 1812 | 3237 | 0.5599 | 0.4493 |
Hs 578T | XMD16-144 | 0.12 | uM | LJP5 | 72 | hr | 929 | 1375 | 3237 | 0.4249 | 0.2432 |
Hs 578T | XMD16-144 | 0.37 | uM | LJP5 | 72 | hr | 929 | 1400 | 3237 | 0.4328 | 0.2560 |
Hs 578T | XMD16-144 | 1.11 | uM | LJP5 | 72 | hr | 929 | 1318 | 3237 | 0.4070 | 0.2138 |
Hs 578T | XMD16-144 | 3.33 | uM | LJP5 | 72 | hr | 929 | 1009 | 3237 | 0.3117 | 0.0468 |
Hs 578T | XMD16-144 | 10 | uM | LJP5 | 72 | hr | 929 | 832 | 3237 | 0.2569 | -0.0605 |
Hs 578T | Erlotinib | 0.04 | uM | LJP5 | 72 | hr | 929 | 3145 | 3237 | 0.9717 | 0.9683 |
Hs 578T | Erlotinib | 0.12 | uM | LJP5 | 72 | hr | 929 | 3071 | 3237 | 0.9489 | 0.9426 |
Hs 578T | Erlotinib | 0.37 | uM | LJP5 | 72 | hr | 929 | 3071 | 3237 | 0.9488 | 0.9424 |
Hs 578T | Erlotinib | 1.11 | uM | LJP5 | 72 | hr | 929 | 3059 | 3237 | 0.9453 | 0.9385 |
Hs 578T | Erlotinib | 3.33 | uM | LJP5 | 72 | hr | 929 | 2989 | 3237 | 0.9234 | 0.9133 |